Cooperative Advancement of Medical Education

What holds for care and discovery holds for educational formation, and here the arithmetic is unusually plain.

The previous chapter set out what the future curriculum requires. It starts with a full biomedical education. To that it adds structured depth in data science and artificial intelligence, complexity, engineering and device development, health economics, regulatory frameworks, design, and the human sciences; simulation infrastructure for immersive team rehearsal; the global formation argued for in Chapter X; and continuing education reconceived as a vehicle for growth across forty years. No medical school possesses that faculty, and most possess a portion of it unevenly, with a single individual carrying a subject alone. The gap between what the curriculum demands and what any one institution holds is a counting problem, and cooperation is the only available answer.

What Medical Schools Can Share

The counting problem is best stated in numbers. Take the twelve foundational elements of the preceding chapter and ask what genuine coverage of even one requires: enough faculty to teach a sequence rather than a lecture, to supervise projects, to assess the work, and to survive a departure or a sabbatical, which is realistically three to five people per element. Twelve elements at that density is something on the order of fifty faculty whose primary work is this material.

Few medical schools anywhere hold more than a handful, and most hold one or two individuals carrying a subject alone and teaching it beside a full clinical load. The gap cannot be closed by recruitment, because the same shortage operates in every school competing for the same people. Ten schools sharing, however, need five people each. That is the whole of the argument for cooperation, and it is plain arithmetic, not just a vague sense.

The first candidate is faculty. A school with two people working in computational pathology can offer an elective. Ten such schools acting together can staff a genuine track, and can give each of those twenty a cohort large enough to justify building a curriculum instead of improvising one. The mechanisms are unexotic, among them joint and adjunct appointments, visiting terms, cross-registration, and jointly owned courses, and their scarcity reflects administrative habit rather than difficulty.

The rest follows the same logic. Technology and infrastructure: simulation centers, extended-reality environments, and secure compute are capital-intensive and chronically under-used at any one site. The shared virtual clinic in which learners from different schools and countries run a resuscitation together, imagined both in the previous chapter and at the third rung of the interprofessional ladder in Chapter VIII, is a consortium requirement, not a technology one.

Curriculum and assessment: shared module libraries, common assessment items, and shared evaluation of what works. Students and data: cross-institutional electives, joint capstones, and the outcomes analysis argued for in the previous chapter, which requires trainee numbers no single institution has.

A line of sight comes from the American Medical Association's Accelerating Change in Medical Education consortium, which from 2013 brought an initial group of schools, later more than thirty, into a standing collaboration with common goals and shared evaluation. Its products are now widely adopted: health systems science as an explicit third pillar, competency-based pathways, and the master adaptive learner model invoked in the previous chapter.

Bridging the Academy Outward

Cooperation among medical schools is a challenging enough half. The harder and more consequential half is formalized connection to institutions that are not medical schools at all.

To industry first, meaning pharmaceutical, biotechnology, device, diagnostics, and health technology, where the case is educational, not commercial, and should be made carefully because the reflex against it is understandable. A physician who has never seen how a therapeutic is discovered, tested, regulated, manufactured, priced, and distributed is not thereby impartial. They are uninformed about the system determining what they can offer a patient.

Structured placements in research and development, regulatory affairs, and manufacturing produce literacy under the disclosure and curricular-control safeguards the profession already knows how to write. And to finance, specifically biotechnology finance, where translation is in practice decided: a trainee who has sat through a venture diligence session grasps that the translational gap of Chapter II is as much a capital phenomenon as a scientific one.

And to entities technically distant from biomedicine altogether, where the distance is the point: schools of engineering and computer science; design schools; law and public policy; anthropology, history, and philosophy; national laboratories; aerospace and defense research organizations, with their hard-won discipline in human factors, autonomy, and reliability engineering; agricultural and veterinary faculties, whose One Health perspective Chapter X invokes; and the arts. Exposure of this kind is cut first under pressure, which misunderstands what it is for. The consilience argued for in Chapter VIII is a practiced capability, practicable only against a discipline whose assumptions differ from one's own.

This is also the natural home for the global formation of Chapter X. That chapter's recommendation, that grasp of global health be structural instead of optional and that much of it need not require boarding a plane, depends on partner institutions willing to run joint case conferences, shared journal clubs, cross-national morbidity and mortality reviews, and collaborative quality-improvement projects. Joint programs among the schools of one country, reaching out together to other countries and regions, distribute cost and give smaller institutions access they could not build unilaterally.

Four Programs Worth Studying

Each of these already does part of what is described above, and between them they cover the transdisciplinary and the global.

Stanford University School of Medicine: the Byers Center for Biodesign. Established in 2001, Biodesign teaches a need-driven innovation process through a fellowship and course in which physicians and medical students work in deliberately mixed teams alongside engineers, business students, and designers, moving from unmet clinical need through prototyping to intellectual property, regulatory strategy, reimbursement, and business model. The outcomes show the ambition: fifty-eight health technology companies founded from fellowship and class projects, ninety-one more launched by alumni afterwards, and technologies from the fellowship reaching over four hundred and forty thousand patients directly. The model has been exported through partnerships in India, Japan, and Singapore.⁹¹

The Harvard-MIT Program in Health Sciences and Technology. Founded in 1970 and among the oldest interdisciplinary programs of its kind, HST runs an MD track conferred by Harvard Medical School and a Medical Engineering and Medical Physics doctorate conferred by MIT or Harvard. The doctoral track is the relevant piece.

Applicants typically arrive with degrees in engineering or a quantitative science, whether chemistry, physics, computer science, or computational neuroscience, and are asked not to abandon that discipline but to deepen it, choosing a technical concentration while taking preclinical medical science alongside MD students and undertaking structured clinical immersion. Its answer to how one draws computer scientists and engineers into medicine declines the usual framing: the goal is to make the engineer fluent in the language and culture of medicine while they remain an engineer, not to convert them. The Carle Illinois College of Medicine offers a complementary answer, built so that engineering runs through the required curriculum.⁹²

EIT Health, one of the European Institute of Innovation and Technology's Knowledge and Innovation Communities, is a standing partnership of universities, companies, research centers, and public bodies. Its education arm awards the EIT Label to master's and doctoral programs delivered by consortia of European universities, and the label's conditions are the interesting part: innovation and entrepreneurship content, mandatory international mobility, challenge-based learning, and substantive industry involvement. The credential itself encodes the connections, since a program cannot carry the label unless it is cooperative, mobile, and industry-linked.⁹³

The Consortium of Universities for Global Health, founded in 2008 with Gates and Rockefeller support and now well over a hundred member institutions worldwide, strengthens the role of universities in global health education, research, and service. Two features matter here: a Trainee Advisory Committee of roughly twenty-five students and early-career professionals from institutions around the world, formally integrated into the organization's committee structure; and a Global Health Competencies Toolkit, now in a third edition, extended to planetary health and the decolonization of global health. Chapter X warned that the failure mode of global health education is the trip that changes nobody's practice. The frameworks that prevent it already exist and are held collectively.⁹⁴

The visioning literature points the same way. Reports commissioned independently across several systems converge on collaborative structure as the organizing recommendation for biomedical research and the formation that feeds it. In the United States, these include the National Academy of Medicine's 2024 assessment and the 2014 convergence report; in Europe, the Innovative Health Initiative's cross-sectoral research agenda and the European Health Data Space; and in Japan, the creation of the Japan Agency for Medical Research and Development in 2015, consolidating coordination divided across ministries. The Lancet Commission on the education of health professionals for the twenty-first century located the failure of professional education in fragmented and static curricula, making interdependence in education, through networks, alliances, and consortia among institutions, a core reform.⁹⁵

Initiatives aimed specifically at students and trainees sit alongside these. The Fogarty International Center's fellows and scholars programs, delivered through consortia of universities in high-income and in low- and middle-income countries, place doctoral and postdoctoral trainees in year-long mentored research at partner sites. Regional bodies such as the African Forum for Research and Education in Health coordinate training across national systems rather than exporting into them. A school wanting serious collaborative global research experience for its trainees needs to join.

Beyond the Undergraduate Years

It would be a mistake to treat any of this as belonging to undergraduate medical education alone, and the mistake is common, since consortium thinking in education tends to stop at the medical student. In graduate medical education the case is stronger still. The previous chapter argued for personalized, curated cross-training reaching deliberately beyond biomedicine, and observed that the very property making those domains valuable, that they serve a pathologist and a pediatrician alike, is why no specialty board has taken ownership of them. That orphan status is an argument for consortium ownership: a shared catalog of such modules, taught once and well by faculty drawn from many institutions, credentialed in common.

Cooperation of this kind also reaches a problem that begins long before any of the institutions discussed here take custody of a trainee. The physician pipeline has two imbalances that no single school can address. The first is between domestic and international pathways, whose relative weighting is set by immigration and licensure policy rather than by educational planning. The second is at the earliest stages, in the K-12 years, where interest in science is formed or lost and where the demographic composition of the eventual profession is substantially determined.

Medical schools have historically treated both as external conditions to be adapted to. Acting collectively they are closer to being levers: consortium-scale outreach into secondary and primary education, shared pathway programs, and a common evidence base on what actually shifts the composition of an applicant pool. The pipeline is a counting problem too, and it fails earlier than the curriculum does.

In continuing medical education the opportunity is largest, and there connection becomes creative. The previous chapter argued that continuing education should convert from an informal check that a physician remains minimally current into the mechanism of genuine lifelong learning: the means to branch a career, enter a new arena, and sustain structured sub-specialization across decades. No single institution can offer that to its own physicians. A consortium can, through a shared catalog of longitudinal programs, sabbatical-style immersions hosted by partner institutions, industry laboratories, regulatory agencies, or national laboratories, and a network willing to host the mid-career physician re-entering an immersive learning environment.

What makes learning meaningful in mid-career is rarely content in the abstract. It is the company: being placed among people doing work one has not done, in a setting where one is a novice again and it is safe to be one. Those are the conditions identified in the previous chapter as producing adaptive rather than routine expertise, and a single employer almost never supplies them to its own senior staff. Connection is therefore not merely the delivery mechanism for lifelong learning. It is a large part of its substance.

Medical schools, and the bodies representing them nationally and internationally, should treat cooperative educational infrastructure as core institutional strategy, not as goodwill. They should begin with a few shared assets whose value is immediately legible: a common catalog of specialty-agnostic technoscientific modules across the full continuum; a shared simulation and extended-reality environment for cross-institutional team training; a common framework for global health formation; and shared measurement of educational outcomes. Together they would constitute the educational half of the convergence this report has argued for throughout.

What remains is to draw the threads together.

One question remains: what happens if the bodies addressed here decline to act. The coalition mechanism requires no permission. A small group of institutions can build a shared module catalog, teach it, assess it, and publish the outcomes without any accreditor agreeing in advance, and the precedents in engineering, aviation, and architecture all began there, with standards following demonstration rather than preceding it. The reforms proposed above would be faster with the certifying bodies inside them and are not conditional on their participation. A profession guided by a report arguing for proactivity should not wait for permission, and it does not have to.